Treatment Options for Epilepsy
Anti-epileptic drugs (AEDs) are the frontline therapy for epilepsy, with surgical options and vagus nerve stimulation available for refractory cases that don't respond to medication. 1
First-Line Treatment: Anti-Epileptic Drugs (AEDs)
- Monotherapy with a standard anti-epileptic drug should be the initial approach for treating convulsive epilepsy 1
- Approximately 47% of patients achieve complete seizure control with the first AED attempted, and an additional 14% with the second or third AED 1, 2
- Standard first-line AEDs include:
- For women with epilepsy, valproic acid should be avoided if possible due to teratogenic risks 1
Treatment Algorithm for New-Onset Epilepsy
- Start with monotherapy using a single AED appropriate for the seizure type 1, 3
- Titrate to optimal dose - if seizures continue, increase to maximum tolerated dose before considering alternatives 3
- If first AED fails, try a second AED monotherapy 2
- If second AED fails, consider:
- If medication-resistant (failure of two or more appropriate AEDs), evaluate for surgical options or neurostimulation 1
Management of Status Epilepticus
- First-line: Intravenous benzodiazepines (lorazepam preferred over diazepam if available) 1
- Second-line (for refractory status epilepticus): Additional antiepileptic medication should be administered (Level A recommendation) 1
- While treating status epilepticus, simultaneously search for and address underlying causes (hypoglycemia, hyponatremia, infection, etc.) 1
Treatment of Refractory Epilepsy
- Refractory epilepsy affects 20-40% of newly diagnosed patients and is defined as failure to control seizures despite trying two or more appropriate AEDs 1, 5
- Options for refractory epilepsy include:
1. Surgical Resection
- Highly effective for suitable candidates - approximately 52% remain seizure-free 5 years post-surgery 1
- Not all patients are candidates due to:
- Location of seizure focus in critical brain regions
- Multiple seizure foci
- Medical contraindications to surgery 1
2. Vagus Nerve Stimulation (VNS)
- FDA-approved in 1997 as adjunctive therapy for refractory epilepsy 1
- Involves implanting helical cuff electrodes on the left cervical vagal trunk connected to an implanted pulse generator 1
- Approximately 51% of patients experience ≥50% reduction in seizure frequency with VNS 1
- Both used for seizure prevention and acute seizure termination 1
3. Rational Polytherapy
- Combinations showing synergistic effects include:
- Lamotrigine + valproate
- Levetiracetam + valproate
- Topiramate + carbamazepine 4
- Avoid combinations with known antagonistic effects:
- Lamotrigine + carbamazepine
- Lamotrigine + oxcarbazepine 4
Special Considerations
- For pregnant women: Use AED monotherapy at minimum effective dose; avoid valproate; take folic acid supplementation; standard breastfeeding recommendations apply for standard AEDs 1
- For patients with intellectual disability: The same range of investigations and treatments should be available; when possible, consider valproic acid or carbamazepine instead of phenytoin or phenobarbital due to lower risk of behavioral adverse effects 1
- For febrile seizures: Simple febrile seizures generally don't require long-term AED treatment; complex febrile seizures may benefit from prophylactic intermittent diazepam during febrile illness 1
Treatment Discontinuation
- Consider discontinuation of AED treatment after 2 seizure-free years 1
- Decision should involve the patient and family, considering clinical, social, and personal factors 1
- Approximately 70% of patients with epilepsy can achieve seizure freedom with optimum AED therapy 3